Dr Graeme Brown
Director of Technology Transfer at QMUL & Executive Director of QMI
With 16 years’ experience of commercialising university research, Graeme is responsible for the delivery of QMI’s technology transfer services and for the overall management of QMUL’s shareholder interests in its subsidiary companies and technology spinout portfolio.
Having trained and worked for a number of years as a scientist in the field of human molecular genetics, Graeme spent two years at the Wellcome Trust before joining QMUL in 2003 as business development manager, becoming Director of Technology Transfer in 2005.Over the period, Graeme has been involved in the development of many successful licences and spinouts, and has held board positions on various QMUL spinout companies.
+44 (0)207 882 3107
Technology Transfer (Tech, Engineering & Creative) Team
Dr Adam Daykin
Head of Technology Transfer
Adam has over 15 years’ experience of technology commercialisation. Following a PhD from Liverpool University in 1990, he moved from research to QinetiQ, the defence, aerospace and security expert, where he worked first as a project manager and then as a business group manager. In 2002 he moved to healthcare company Weston Medical as IP manager, followed by a period at NHS Innovations London, focusing on medical devices. At QMI, Adam has established six spin-out companies and executed in excess of 40 technology licences.
+44 (0)207 882 5117
Ben has over 2 years’ experience in technology commercialisation. Following an undergraduate degree in Biochemistry, including a year with GSK, he moved from pharmaceuticals into engineering, and is currently completing a PhD in Tissue Engineering & Regenerative Medicine from the University of Leeds. During his PhD, he joined Medipex, the Yorkshire-based healthcare innovation hub, where he was responsible for managing the development of new medical devices from NHS Trusts across the region and advising on IP strategy. At QMI, Ben is responsible for the output from the Institute of Bioengineering.
Technology Transfer (BioPharma) Team
Dr Michele Hill-Perkins
Head of Technology Transfer
Michele started her career as a research scientist in academia and then the biotechnology industry. She has held senior business development roles at Cancer Research Technology and the Wellcome Trust where she was involved in licensing transactions and the provision of “development gap” funding to spin-out companies in the biotechnology and pharmaceutical sector. Prior to joining QMI, Michele worked as Project Director at Partnerships UK in the science commercialisation team, advising public sector organisations on commercial strategy, and also in its venture capital arm, PUK Ventures, advising on life science and medtech investments. Michele was investment manager at the Children’s Investment Fund Foundation responsible for investments in child survival. Michele has a PhD in biochemistry, an MSc from University College, London and an MA (Oxon) in Human Sciences.
Tel: +44 (0)20 7882 5581
Mob: +44 (0)7825402975
Eleftheria is a member of the Biopharma team and focuses on the commercialisation of technologies in the life sciences arena. Prior to joining QMI, she worked in Brunel University’s technology transfer office after completing studies in Intellectual Property Law from the same university. These studies certified her as a part- qualified patent attorney. She began her career as a molecular biologist with a first class honours MSc in “Molecular Basis of Human Disease” from University of Crete, Greece. She has worked as a scholar in acclaimed research laboratories worldwide, with scientific findings in colon, breast and ovarian cancer, and DNA damage and repair. After her post-graduate studies, she worked at University College London as an honorary researcher. Eleftheria also holds an esteemed tech transfer career training fellowship from LifeArc and AUTM, which supports her professional development as well as being part of the AUTM small tech transfer offices’ committee.
Tel: +44 (0)20 7882 7731
Mob: +44 (0)7920 270995
Dr Liisa Chisty
Liisa trained as a scientist and her post-doctoral work involved the development of a biosensor for single-stranded DNA on project funded by MRCT (LifeArc). She worked as the primary scientist designing the project and experiments and contributed to the drafting of the patent as an inventor and management of the project with an MRCT technology transfer manager. Liisa joined QMI after holding several roles at technology transfer offices across London. These include IP management and commercialisation roles at Imperial Innovations and UCL Business, and at Ximbio, Cancer Research UK, and covered technologies from biopharma to natural sciences. At Ximbio, Liisa’s role included management of relationships and new accounts with universities and research institutes in the UK, Scandinavia, Baltics and Australasia.
Liisa holds a 1st class honours degree in Molecular Genetics from King’s College London, and a PhD from UCL, which she completed on a Wellcome Trust Interdisciplinary PhD Programme in Structural, Chemical and Computational Biology and the experimental work was done at MRC National Institute for Medical Research. Liisa also has several years of experience in self-employment.
At QMI, Liisa helps to commercialisation technologies from the Biopharma sector.
Tel: +44 (0)20 7882 5278
Mob: +44 (0)7944 993374
Reitesh joined QMI in 2008 and became Finance Director in 2012. He is responsible for the financial oversight of the company and its subsidiaries. Prior to QMI, he worked in new media for over seven years and gained valuable insight into managing the finances of a growing company. Reitesh has been a member of the Chartered Institute of Management Accountants for over 15 years.
+44 (0)207 882 5117
Safo is responsible for managing the College’s patent portfolio which includes database, renewals and contracts management as well as liaising with academics, patent attorneys, licensees and with the Technology Transfer Managers. Prior to joining QMI in 2008, she worked for six years at Sharp Laboratories of Europe Ltd as a patent administrator. She started her career in Qiagen KK’s BioRobot Team in Tokyo.
+44 (0)207 882 5123
Innovation China UK (ICUK)
Manyi has been working in the UK higher education knowledge transfer field over the last 15 years and leading the ICUK programme since 2007. She also serves as the Board Directors of Queen Mary Research and Consulting (Hong Kong) Limited, Mary Education Management Advisory (Beijing) Co. Ltd and Juwei Co. Limited. She is a frequent contributor to the UK government policy research in UK-China joint innovation, intellectual property protection and technology commercialisation.
Before joining the public sector, Manyi was the founding member and senior executive of two technology start-ups specialised in Bioinformatics and Engineering, responsible for in international business development and licensing and based in London and Shanghai over 8 years. Manyi has BSc in Engineering from Tongji University, a MBA in Innovation Management from Imperial College London, and a LLM in Intellectual Property Laws from University of London.
+44 (0)207 882 8341
Senior Partnership Manager
Olivia supports the Global Innovation Partnerships team with international collaborations and commercialisation in low and middle income countries. With over 15 years’ experience of working in technology development, clinical research, and health tech regulation. Olivia developed her passionate on improving and influencing health policy and technology whilst working at the National Institute for Health Research, the Academic Health Science Networks, and Nesta innovation charity. From her experience at Digital Health.London accelerator, Olivia developed her love of working with SMEs and start-ups, and brings specialised knowledge from supporting Digital Health companies with NHS technology adoption.